Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (3,803 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

National Physical Therapy Month Is Here

Oct 1, 2024/Article

Access dozens of marketing assets to communicate the benefits of physical therapy for falls prevention this October.

Physical Activity Guidelines for Americans, 2nd edition

Jan 1, 2018/CPG

The second edition of the Physical Activity Guidelines for Americans provides scientific guidance to help people ages 3 years and older improve their health through participation in regular physical activity.

APTA-Backed Bill Presses for Medicare Advantage Prior Authorization Reforms

May 17, 2021/News

The legislation would require MA plans to share data, provide transparency, create more efficient systems, and do a better job of listening.

APTA President’s Note | The Road Ahead

May 1, 2025/Column

Learn how APTA President Kyle Covington is thinking boldly about the future and every member's role in evolving our profession.

Researcher Spotlight

May 1, 2024/Column

Julie Fritz, PT, PhD, FAPTA, shares experiences translating research into practice and being a peer reviewer.

Researcher Spotlight

Dec 1, 2024/Article

Jim Gordon, PT, EdD, FAPTA, takes stock of his research journey and the challenges that remain.

Laycock Pelvic Floor Manual Muscle Test Scale

Aug 23, 2017/Test & Measure

A 6 point Oxford scale (0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong) used during internal examination to measure pelvic floor muscle strength in women. (4)

Harnessed Yet Unleashed

Oct 1, 2015/Column

A resolute patient moves forward-on a treadmill.

Viewpoints: July 2024

Jul 1, 2024/Column

President's Note; Opinion

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]